Submitted by THE DONALD REPORT
War on ivermectin rages as feds buy Big Pharma’s expensive copy
Exclusive: Joel S. Hirschhorn predicts firms will switch from pushing vax to new antiviral meds
In my book “Pandemic Blunder,” I made the case with data that using cheap, safe and effective generics like IVM and hydroxychloroquine would prevent 80% or more of COVID deaths. Esteemed physician Dr. Peter McCollough later said 85%. For the U.S., that means over 500,000 lives could have been saved, and globally over 4 million lives. Meanwhile, hundreds of thousands of people worldwide have died from COVID vaccines, the failed solution to the pandemic.
Merck, a maker of IVM, is getting much positive press coverage for its forthcoming prescription oral antiviral (molnupiravir). It is designed to replace IVM, since they cannot make big money from ivermectin. The FDA will soon give molnupiravir emergency use authorization because of the emerging clarity that COVID vaccines do NOT work effectively or safely.
The fact that the Washington Post claims that what Merck has created is the “first COVID-fighting pill” illustrates how awful big media have been in ignoring the proven benefits of the IVM and hydroxychloroquine generics – and ignoring the many failures of COVID vaccines. In its Oct. 2 front-page story on the new Merck pill, the Post did not even mention IVM or present any data showing IVM as proven even more effective than the new expensive drug tested on only hundreds of people for a short period. In contrast, IVM has been used successfully on hundreds of thousands of people to treat and prevent COVID-19.
Speaking as someone who is using IVM as a prophylactic, here is what I have seen in recent times. Though getting a prescription for it is very difficult and stressful, it can be done through a number of websites. But then the battle just begins. Many pharmacies, especially big chain ones, will not fill IVM prescriptions if there is any evidence that it is being used to fight COVID. And then you will likely discover, as I did, that virtually no pharmacy (typically small community ones) that will fill such prescriptions has any IVM. That’s right. There is a national shortage of ivermectin because of huge demand in recent months and because U.S. makers have not escalated production.
TRENDING: Ashli Babbitt coverup sparks federal action
Probably, millions of vaccine resisters are using IVM, especially those resisting booster shots.
Can you still get it? Yes, and even without a prescription – but it will have to come from India, which has many makers of IVM. It can take many weeks to get it, but the cost is a tiny fraction of what U.S. pharmacies charged when they did have it in stock. Rather than $4 or $5 for a 3 mg pill, you can buy 12 mg pills for way under $1 a pill….”